🇺🇸 Estradiol Ring in United States

FDA authorised Estradiol Ring on 26 April 1996 · 10 US adverse-event reports

Marketing authorisations

FDA — authorised 26 April 1996

  • Application: NDA020472
  • Marketing authorisation holder: PFIZER
  • Local brand name: ESTRING
  • Indication: INSERT, EXTENDED RELEASE — VAGINAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Biliary Tract Infection — 1 report (10%)
  2. Cerebrovascular Accident — 1 report (10%)
  3. Diabetes Mellitus — 1 report (10%)
  4. Hepatic Cancer — 1 report (10%)
  5. Hepatic Infection — 1 report (10%)
  6. Intra-Abdominal Fluid Collection — 1 report (10%)
  7. Pulmonary Embolism — 1 report (10%)
  8. Pulmonary Oedema — 1 report (10%)
  9. Sepsis — 1 report (10%)
  10. Treatment Failure — 1 report (10%)

Source database →

Estradiol Ring in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Estradiol Ring approved in United States?

Yes. FDA authorised it on 26 April 1996; FDA has authorised it.

Who is the marketing authorisation holder for Estradiol Ring in United States?

PFIZER holds the US marketing authorisation.